放线菌：抗生素生产者。
Actinomycetes: The Antibiotics Producers.
作者信息
Mast Yvonne, Stegmann Evi
机构信息
Department of Bioresources for Bioeconomy and Health Research, Leibniz Institute DSMZ-German Culture Collection for Microorganisms and Cell Cultures, 38124 Braunschweig, Germany.
Institute for Microbiology, Technical University of Braunschweig, 38106 Braunschweig, Germany.
出版信息
Antibiotics (Basel). 2019 Jul 29;8(3):105. doi: 10.3390/antibiotics8030105.
Abstract
Actinomycetes are well known as an inexhaustible source for antibiotics [...].
摘要
放线菌作为抗生素的无尽来源而广为人知[...]。
相似文献
1
Actinomycetes: The Antibiotics Producers.放线菌：抗生素生产者。
Antibiotics (Basel). 2019 Jul 29;8(3):105. doi: 10.3390/antibiotics8030105.
2
Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics.放线菌，一种天然抗生素的无尽来源。
Antibiotics (Basel). 2018 May 24;7(2):45. doi: 10.3390/antibiotics7020045.
3
Correction: Yōko, T., et al. Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics. Antibiotics 2018, 7, 45.更正：Yōko, T.等人。放线菌，天然抗生素的无尽来源。《抗生素》2018年，第7卷，第45期。
Antibiotics (Basel). 2018 Aug 14;7(3):74. doi: 10.3390/antibiotics7030074.
4
Mechanism-Based Approach to New Antibiotic Producers Screening among Actinomycetes in the Course of the Citizen Science Project.公民科学项目中基于机制的放线菌新抗生素产生菌筛选方法
Antibiotics (Basel). 2022 Sep 5;11(9):1198. doi: 10.3390/antibiotics11091198.
5
Secondary metabolites and biodiversity of actinomycetes.放线菌的次生代谢产物与生物多样性
J Genet Eng Biotechnol. 2021 May 12;19(1):72. doi: 10.1186/s43141-021-00156-9.
6
Antibacterial agents from actinomycetes - a review.来自放线菌的抗菌剂——综述
Front Biosci (Elite Ed). 2012 Jan 1;4(1):240-53. doi: 10.2741/373.
7
Novel bioactive compounds from actinomycetes.来自放线菌的新型生物活性化合物。
Res Microbiol. 1993 Oct;144(8):661-3. doi: 10.1016/0923-2508(93)90071-9.
8
Actinomycetes - The Repertoire of Diverse Bioactive Chemical Molecules: From Structures to Antibiotics.放线菌——多样生物活性化学分子的宝库：从结构到抗生素
Curr Top Med Chem. 2024 Mar 11. doi: 10.2174/0115680266282919240224130345.
9
Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?组学时代挖掘放线菌以获取新型抗生素：我们是否准备好利用这一新模式？
Antibiotics (Basel). 2018 Sep 25;7(4):85. doi: 10.3390/antibiotics7040085.
10
Actinomycete-Derived Polyketides as a Source of Antibiotics and Lead Structures for the Development of New Antimicrobial Drugs.放线菌来源的聚酮化合物作为抗生素来源及新型抗菌药物开发的先导结构
Antibiotics (Basel). 2019 Sep 20;8(4):157. doi: 10.3390/antibiotics8040157.
引用本文的文献
1
Secondary Metabolites from a New Antibiotic-Producing Endophytic Streptomyces Isolate Inhibited Pathogenic and Multidrug-Resistant Strains.一种新的产抗生素内生链霉菌分离株产生的次生代谢产物可抑制致病性和多重耐药菌株。
Trop Med Infect Dis. 2025 Apr 23;10(5):117. doi: 10.3390/tropicalmed10050117.
2
Bioactive Secondary Metabolites from an Arctic Marine-Derived Strain, sp. MNP-1, Using the OSMAC Strategy.采用OSMAC策略从北极海洋来源菌株sp. MNP-1中获得的生物活性次生代谢产物
Molecules. 2025 Apr 8;30(8):1657. doi: 10.3390/molecules30081657.
3
Exploring bioactive molecules released during inter- and intraspecific competition: A paradigm for novel antiparasitic drug discovery and design for human use.探索种间和种内竞争过程中释放的生物活性分子：一种用于发现和设计新型人类用抗寄生虫药物的范例。
Curr Res Parasitol Vector Borne Dis. 2025 Mar 25;7:100256. doi: 10.1016/j.crpvbd.2025.100256. eCollection 2025.
4
Metabolites Discovery from : Exploring the Potential of Desert Microorganisms.从沙漠微生物中探索潜力的代谢物发现
Biology (Basel). 2025 Feb 6;14(2):164. doi: 10.3390/biology14020164.
5
Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria.关于对抗耐药细菌的CRISPR策略的当前知识
Antibiotics (Basel). 2024 Nov 27;13(12):1141. doi: 10.3390/antibiotics13121141.
6
Beyond traditional screening: Unveiling antibiotic potentials of actinomycetes in extreme environments.超越传统筛选：揭示极端环境中放线菌的抗生素潜力。
Heliyon. 2024 Nov 13;10(22):e40371. doi: 10.1016/j.heliyon.2024.e40371. eCollection 2024 Nov 30.
7
Diversity and Bioprospection of Gram-positive Bacteria Derived from a Mayan Sinkhole.从玛雅沉洞中分离出的革兰氏阳性菌的多样性及生物勘探。
Microb Ecol. 2024 May 29;87(1):77. doi: 10.1007/s00248-024-02392-1.
8
Impact of Rhizospheric Microbiome on Rice Cultivation.根际微生物组对水稻种植的影响。
Curr Microbiol. 2024 May 23;81(7):188. doi: 10.1007/s00284-024-03703-y.
9
Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.结核分枝杆菌 Pks13、PknG 与极端微生物活性成分相互作用的分子对接、分子动力学模拟及结合自由能研究。
Sci Rep. 2024 Mar 21;14(1):6794. doi: 10.1038/s41598-024-57124-9.
10
Metagenomics-based exploration of key soil microorganisms contributing to continuously planted growth inhibition and their interactions with soil nutrient transformation.基于宏基因组学探究导致连作生长抑制的关键土壤微生物及其与土壤养分转化的相互作用。
Front Plant Sci. 2023 Dec 6;14:1324184. doi: 10.3389/fpls.2023.1324184. eCollection 2023.
本文引用的文献
1
The antiSMASH database version 2: a comprehensive resource on secondary metabolite biosynthetic gene clusters.反物质 SMASH 数据库版本 2：二次代谢生物合成基因簇的综合资源。
Nucleic Acids Res. 2019 Jan 8;47(D1):D625-D630. doi: 10.1093/nar/gky1060.
2
Comparative Genomics among Closely Related Strains Revealed Specialized Metabolite Biosynthetic Gene Cluster Diversity.近缘菌株间的比较基因组学揭示了特殊代谢物生物合成基因簇的多样性。
Antibiotics (Basel). 2018 Oct 2;7(4):86. doi: 10.3390/antibiotics7040086.
3
Mining Actinomycetes for Novel Antibiotics in the Omics Era: Are We Ready to Exploit This New Paradigm?组学时代挖掘放线菌以获取新型抗生素：我们是否准备好利用这一新模式？
Antibiotics (Basel). 2018 Sep 25;7(4):85. doi: 10.3390/antibiotics7040085.
4
Natural Products from Actinobacteria Associated with Fungus-Growing Termites.与培菌白蚁相关的放线菌产生的天然产物
Antibiotics (Basel). 2018 Sep 13;7(3):83. doi: 10.3390/antibiotics7030083.
5
Acyltransferases as Tools for Polyketide Synthase Engineering.酰基转移酶作为聚酮合酶工程的工具
Antibiotics (Basel). 2018 Jul 18;7(3):62. doi: 10.3390/antibiotics7030062.
6
Production of β-Lactamase Inhibitors by Species.不同菌种产生β-内酰胺酶抑制剂的情况
Antibiotics (Basel). 2018 Jul 17;7(3):61. doi: 10.3390/antibiotics7030061.
7
Lysoquinone-TH1, a New Polyphenolic Tridecaketide Produced by Expressing the Lysolipin Minimal PKS II in .溶血醌-TH1，一种通过在……中表达溶血磷脂最小聚酮合酶II产生的新型多酚十三酮
Antibiotics (Basel). 2018 Jun 28;7(3):53. doi: 10.3390/antibiotics7030053.
8
Novel Polyethers from Screening Actinoallomurus spp.从筛选放线异壁放线菌属中获得的新型聚醚
Antibiotics (Basel). 2018 Jun 14;7(2):47. doi: 10.3390/antibiotics7020047.
9
Actinomycetes, an Inexhaustible Source of Naturally Occurring Antibiotics.放线菌，一种天然抗生素的无尽来源。
Antibiotics (Basel). 2018 May 24;7(2):45. doi: 10.3390/antibiotics7020045.
10
Concepts and Methods to Access Novel Antibiotics from Actinomycetes.从放线菌中获取新型抗生素的概念与方法
Antibiotics (Basel). 2018 May 22;7(2):44. doi: 10.3390/antibiotics7020044.
Zotero 插件